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avid J. Clark, MD,*† Sara Lessio, MD,* Margaret O’Donoghue, MD,* Con Tsalamandris, MD,†
obert Schainfeld, DO,* Kenneth Rosenfield, MD, FACC*
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OBJECTIVES The aim of this study was to determine the mechanisms and predictors of carotid artery restenosis
after carotid artery stenting (CAS) using serial intravascular ultrasound (IVUS) imaging.
BACKGROUND Carotid artery stenting is increasingly used to treat high-grade obstructive carotid disease, but
our knowledge of carotid in-stent restenosis and remodeling remains limited.
METHODS Post-procedural and 6-month (median 6 months) follow-up quantitative carotid angiography
and IVUS were performed after self-expanding stent deployment in 50 internal carotid
arteries (ICA). The IVUS measurements at multiple designated sites included minimal
luminal diameter, lumen area, stent area (SA), and neointimal hyperplasia area (NIH).
RESULTS Late stent enlargement at follow-up was found at all segments, and the percentage increase
was greatest at the ICA lesion site (mean  SD, 48.9  35.3%). The NIH, expressed as a
percentage of SA, was seen within all segments of the stent and was greatest at the ICA lesion
site (37.3 23.3%). There was a strong positive correlation between the amount of NIH and
late stent enlargement (r  0.64; p  0.001). Immediate post-procedural minimum ICA SA
(r0.37; p 0.01) and stent expansion (r0.44; p 0.001) correlated negatively with
the percentage restenotic area at follow-up.
CONCLUSIONS Although self-expanding carotid stents generate considerable neointimal hyperplasia, the
process is balanced by marked late stent enlargement. Small stent dimensions immediately
post-procedure were associated with a higher risk of restenosis. (J Am Coll Cardiol 2006;
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.01.07647:2390–6) © 2006 by the American College of Cardiology Foundation
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Iarotid artery stenting (CAS) has proved to be a safe and
ffective alternative to endarterectomy to treat severe carotid
tenosis in patients at high-risk for surgery (1–4). Although
he risk of symptomatic restenosis after CAS is very low, up to
0% of patients develop 50% stenosis by angiography or
arotid duplex (4–7). In some patient subgroups, such as
omen and the elderly, it approaches 20% (6).
See page 2397
Serial intravascular ultrasound (IVUS) studies have been
undamental to our understanding of restenosis after balloon-
xpandable, self-expanding, and drug-eluting stent deploy-
ent in coronary arteries (8–13). Self-expanding coronary
tents were found to enlarge significantly over time, but also
nduced greater neointima formation (10–12). Furthermore,
or balloon-expandable coronary stents, smaller immediate
ost-procedural lumen dimensions, as measured by IVUS,
ave been strong predictors of restenosis (8,9).
Ultrasound follow-up studies after CAS have been lim-
ted to externally applied carotid duplex (14,15). Intravas-
ular ultrasound offers a more direct and detailed method to
ssess the carotid arterial response to CAS. Intravascular
From the *Division of Cardiovascular Medicine and Research, St. Elizabeth’s
edical Center of Boston, Boston, Massachusetts; and the †Departments of
ardiology and Medicine, Austin Hospital, Melbourne, Australia. Supported in part
y a grant from Boston Scientific Corporation. Dr. Lessio is deceased.a
Manuscript received October 19, 2005; revised manuscript received January 2,
006, accepted January 16, 2006.ltrasound provides images from within the vessel, has
reater resolution (axially 80 and laterally 200 to 250 m),
oes not have to penetrate extravascular soft tissues, and can
ssess the vessel in three dimensions (14,16). The aim of
his study was to use serial IVUS imaging to understand the
echanisms and determine predictors of restenosis after
AS in patients undergoing CAS due to high surgical risk
or endarterectomy.
ETHODS
tudy population. Carotid artery stenting (CAS), with
djunctive IVUS imaging (before and after stent deploy-
ent in all procedures), was performed in 82 consecutive
atients and 87 arteries at a single center between June 1995
nd December 2000. Of these, follow-up angiography and
VUS was performed in 58 patients and 61 arteries (71%) at
median of 6 months (range 4 to 12 months) after stent
eployment. Of these, 11 arteries were excluded from
nalysis because: 1) the stent was balloon-expandable (6 ar-
eries); 2) the stented segment did not involve the internal
arotid artery (ICA) or distal common carotid artery (CCA)
ifurcation (4 arteries with aorto-ostial CCA lesion loca-
ion); or 3) the IVUS imaging was suboptimal quality
1 artery). The final study group comprised 48 patients and
0 arteries treated with self-expanding stents involving the
CA or CCA/ICA bifurcation.
The baseline characteristics of the 48 patients and 50
rteries are shown in Table 1. These patients were consid-
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June 20, 2006:2390–6 IVUS and Carotid Stent Restenosisred high risk for carotid endarterectomy (CEA) and most
ould have been excluded from the North American Symp-
omatic Carotid Endarterectomy Trial (NASCET) (17). Al-
ost half had known coronary artery disease. Heavy calcifica-
ion was frequently present, one-quarter were restenotic after
EA, and a quarter had contralateral carotid occlusion.
The study was approved by the institutional ethics com-
ittee of St. Elizabeth’s Medical Center of Boston, and all
atients provided written informed consent.
arotid procedure and IVUS imaging protocol. The
AS and IVUS were performed by one experienced operator,
nd procedures were undertaken before the routine use of distal
rotection devices. Procedural data are summarized in Table 1.
he Wallstent (Boston Scientific Corp., Natick, Massachu-
etts) was used in the majority of cases, and the median
elf-expanding stent diameter was 8 mm. The mean pressure
sed to post-dilate the ICA stent was approximately 9 atm and
he average ratio of post-dilation balloon diameter/distal ref-
rence vessel diameter (by IVUS) was 1.16.
Initial IVUS imaging was successfully performed before
AS and immediately after an optimal angiographic result
as obtained. In 5 of 50 (10%) of procedures, the findings
y IVUS led to further intervention: further post-dilation to
istal stent edge (3 arteries) or lesion site ICA (1 artery) and
he placement of an additional stent (1 artery). In these
ases, IVUS was repeated at the end of the procedure.
ollow-up IVUS and selective carotid angiography was
erformed at a median of six months. Intracarotid nitro-
lycerine (dose 100 to 200 g) was administered to all
atients before insertion of the IVUS catheter. Heparin was
dministered to maintain an activated clotting time between
00 s and 250 s. The transducer was positioned in the
on-tapered distal segment of the ICA, and then system-
tically pulled back through the stented portion of the ICA
nd CCA and into the guiding catheter or sheath.
The IVUS studies were performed using a commercially
vailable system (Boston Scientific Corp.) with 2.6- to
.5-F monorail catheters and 20- to 40-MHz transducers
otated at 1,800 rpm. Motorized transducer pullback was
sed at a speed of 0.5 mm/s. Studies were recorded on
igh-resolution s-VHS tape for off-line analysis.
The in-hospital and 30-day outcomes from our experience
Abbreviations and Acronyms
CAS  carotid artery stenting
CCA  common carotid artery
CEA  carotid endarterectomy
EEM  external elastic membrane
ICA  internal carotid artery
IVUS  intravascular ultrasound
LA  luminal area
MLD  minimal luminal diameter
NIH  neointimal hyperplasia area
QCA  quantitative carotid angiography
SA  stent areaith IVUS-guided CAS have been previously reported and are
v
En line with those reported in worldwide registries of CAS
2,3). There were no neurologic events (transient ischemic
ttacks or stroke) at the time of follow-up angiography
nd IVUS.
uantitative angiography and IVUS measurements. Fig-
res 1A to 1C illustrate the specific sites where measure-
ents were made with both IVUS and quantitative carotid
ngiography (QCA). These included the lesion site, the distal
on-tapered ICA reference, and the proximal CCA refer-
nce. Sites within the stent included the original lesion site,
he minimum luminal diameter (MLD) of the ICA and the
CA, and reference sites within the ICA and CCA.
NGIOGRAPHIC ANALYSIS. Multiple angulated views were
aken to define the narrowest lumen diameter before and
fter stenting and at six months. A metallic washer, 12.75
m in diameter, was taped to the skin immediately poste-
ior to the point of carotid bifurcation to ensure accurate
alibration (Fig. 1). Off-line analysis was performed using
igital calipers. The percentage ICA stenosis was defined
s: (1  [MLD/non-tapered portion of the distal carotid
eference])  100, as originally described by the NASCET
ollaborators (17). Qualitative assessment included analysis
or the presence, location and degree of carotid calcification.
able 1. Baseline Characteristics
atient characteristics (n  48)
Age (yrs) 68 (49–85)
Female 29%
Diabetes 29%
Recent acute coronary syndrome (3 months) 21%
Coronary artery disease 46%
Severe comorbidity 19%
LVEF 40% 10%
Met NASCET exclusion criteria 73%
Bilateral carotid artery stents 4%
rtery characteristics (n  50)
Symptomatic 48%
Previous carotid endarterectomy 26%
Contralateral carotid occlusion 28%
ICA distal reference
QCA (mm) 4.6  0.6
IVUS (mm) 4.6  0.7
% angiographic stenosis 80  8
Angiographic calcium 48%
IVUS calcium
Any calcification 62%
2 quadrant superficial 28%
rocedural details (n  50)
Stent type
Wallstent 84%
Smart 8%
Integra 8%
Stent diameter (mm) 8 (6–10)
Stent length (mm) 20 (20–60)
Post-dilation balloon pressure (atm) 9.3  2.2
Post-dilation balloon diameter (mm) 5 (4–7)
Balloon:distal ICA reference ratio 1.16  0.13
ata for continuous variables are mean  SD except where shown as median (range).
ata for categorical variables are proportions.
ICA  internal carotid artery; IVUS  intravascular ultrasound; LVEF  leftentricular ejection fraction; NASCET  North American Symptomatic Carotid
darterectomy Trial; QCA  quantitative carotid angiography.
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IVUS and Carotid Stent Restenosis June 20, 2006:2390–6VUS ANALYSIS. All IVUS measurements and morphologic
nalysis follow current American College of Cardiology
uidelines (16). Analysis was performed solely by an inter-
entional cardiologist, not involved in the stent procedure,
s part of a one-year IVUS fellowship (2). At all the
esignated sites (Fig. 1D), the MLD, lumen area (LA), and
tent area (SA) were measured using computer planimetry
Tape Measure Indec Systems, Palo Alto, California).
dentification of the lesion site pre and post-procedure and
hen at follow-up was achieved by measuring its distance
rom the external carotid artery. Although measurements of
he external elastic membrane (EEM) dimensions were
erformed, acoustic shadowing from the stent and the presence
f heavy calcification frequently obscured the EEM border
nd rendered measurements unreliable; these data were
xcluded from the analysis. Carotid calcification was classi-
ed as superficial or deep. The arc of superficial calcium was
raded as subtending 1, 2, 3, or 4 quadrants.
Immediate post-procedure percentage stent expansion by
VUS was defined as (1  (minimum ICA SA/ICA distal
eference])  100 and (1  [minimum CCA SA/CCA
eference])  100 for the internal and common carotid
rteries, respectively.
The following IVUS calculations were made at each of
he designated ICA and CCA stent segments. Values were
etermined in both absolute amounts (mm2) and percentage
hange (%).
. A. Neointimal hyperplasia area (NIH)  SA follow-up
 LA follow-up (mm2).
igure 1. Designated sites of quantitative carotid angiography (QCA) and
B) post-carotid stent deployment; (C) six-month follow-up. (D) IVUS: (
rtery (ICA) stent post-procedure. 1 distal ICA reference; 2 lesion site
 ICA stent minimal luminal diameter (MLD); 6  ICA stent referenc
line) and lumen area (circle); 10  stent MLD (line) and stent area (cirB. % NIH  (NIH/SA follow-up)  100 (%). C. A. Late stent enlargement at follow-up ( stent)  SA
follow-up  SA post-procedure (mm2).
B. %  stent ( stent/SA post-procedure) 100 (%).
. A. Late lumen loss ( lumen)  LA follow-up  LA
post-procedure (mm2).
B. %  lumen  ( lumen/LA post-procedure)
 100 (%).
The IVUS, instead of QCA, was used to assess the degree
f restenosis. Percentage restenotic area of the ICA stent at
ollow-up was defined as (1  [minimum LA ICA/ICA
istal reference LA])  100.
tatistical methods. Statistical analysis was performed us-
ng StatView (SAS Institute, Cary, North Carolina). Dif-
erences in continuous variables were compared using t tests.
orrelations were analyzed using Pearson correlation, ex-
ept where indicated. Multivariable analysis used analysis of
ovariance (ANCOVA) to adjust associations for additional
ariables. A p value of 0.05 was considered to be “statis-
ically significant,” and 95% confidence limits were used.
esults are presented as mean  SD (continuous variables)
xcept where indicated.
ESULTS
erial IVUS quantitative data. Table 2 summarizes the
VUS measurements immediately post-stent deployment
nd at six-month (median six months) follow-up for the 50
rteries. The minimum post-procedure ICA SA was signif-
cantly less than the distal ICA reference (12.4  4.3 mm2
s. 17.9  5.2 mm2; p  0.001). Post-procedure ICA and
ascular ultrasound (IVUS) measurements. QCA: (A) before intervention;
calcified plaque at lesion site pre-intervention; (Bottom) internal carotid
proximal common carotid artery (CCA) reference; 4 lesion site in-stent;
; 7  CCA stent MLD; 8  CCA stent reference site; 9  lumen MLDintrav
Top)
; 3CA stent expansion by IVUS was 70.6 18.7% and 73.0
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June 20, 2006:2390–6 IVUS and Carotid Stent Restenosis4.0%, respectively. There was a small but significant
p  0.05) reduction in both the proximal and distal refer-
nce vessel lumen at 6-month follow-up.
igure 2. Quantitative intravascular ultrasound assessment (mean  SD) o
umen loss ( lumen) at designated sites of the internal carotid artery (IC
Bottom) Percentage change (%). The p values refer to a comparison of c
able 2. Quantitative IVUS Data
Distal ICA Reference Minimum L
ost-procedure
LA (mm2) 17.9  5.2 12.4 
SA (mm2) — 12.4 
Stent expansion (%) — 70.6 
-month follow-up
LA (mm2) 16.8  5.2* 10.2 
SA (mm2) — 17.6 
IH (mm2) — 7.4 
NIH — 42.4 
ata are mean  SD. The p values refer to a comparison of LA/SA post-procedure
CCA  common carotidartery; LA  luminal area; NIH  neointimal hyperplapen bars  reference site ICA stent; gray bars  minimal lumen diameter CC
**p  0.001.Figure 2 illustrates the relative contribution of late
tent enlargement ( stent) and NIH to late lumen loss
 lumen) at the defined segments within the carotid stent.
stent enlargement ( stent), neointimal hyperplasia area (NIH), and late
d common carotid artery (CCA) stent. (Top) Absolute changes (mm2).
s amongst different segments of the stent. Solid bars  ICA lesion site;
ICA Proximal CCA Reference Minimum Lumen CCA
37.4  13.0 26.5  11.7
— 26.5  11.7
— 73.0  24.0
35.5  13.3* 23.6  12.6*
— 31.0  12.1†
— 7.4  9.2
— 23.8  24.6
s follow-up. *p  0.05. †p  0.01. ‡p  0.001.
  stent area; other abbreviations as in Table 1.f late
A) an
hangeumen
4.3
4.3
18.7
5.8‡
6.4‡
5.2
25.5A stent; ruled bars  reference site CCA stent. *p  0.05; **p  0.01;
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IVUS and Carotid Stent Restenosis June 20, 2006:2390–6he changes are expressed both in absolute amounts (mm2)
nd as a percentage change relative to the reference vessel
Fig. 2).
There was statistically significant (p  0.05) enlargement
f the stent at all segments of the ICA and CCA at follow-up.
he greatest enlargement occurred at the ICA lesion site (p
.001 vs. other stent segments) with a 48.9  35.3%
ncrease in SA at follow-up.
Neointimal hyperplasia was also found within all segments
f the stent. The greatest amount of neointima, as a percentage
f the SA, was at the lesion site of the ICA (37.3  23.3%;
  0.001 vs. other segments). Figure 3 shows that the
bsolute amount of NIH (mm2) at the ICA lesion site
orrelated closely (r  0.64; p  0.0001) with the degree of
ate stent enlargement,  stent (mm2).
The mean late lumen loss as a percentage of the SA was
imilar (p  NS) across all sites within the stent (mean 
EM) (ICA lesion6.4 5.7%; ICA reference6.3
.4%, CCA MLD  11.2  5.9%; and CCA reference 
4.7  4.7%).
igure 3. Correlation between amount of neointimal hyperplasia (NIH,
m2) and late stent enlargement ( stent, mm2) at the internal carotid
rtery lesion site (r  0.64; p  0.001).
igure 4. (Left) Correlation between the immediate post-procedure dist
uantitative carotid angiography (QCA) and percentage restenotic area after six
tent minimal lumen diameter (MLD) (mm) measured by QCA and percentaglinical, procedural and angiographic predictors of
estenosis. The angiographic ICA MLD by QCA imme-
iately post-procedure correlated negatively with the reste-
otic area at follow-up (r0.31; p 0.03), but the distal
CA reference did not (r  0.03; p  0.85) (Fig. 4). No
ignificant difference (p  NS) in percentage restenotic area
as detected among women, symptomatic patients, diabet-
cs, or in arteries with angiographic calcification, contralat-
ral occlusion, or previous CEA (data not shown). There
as also no significant correlation (p  NS) between age,
aximal balloon pressure, or post-dilation balloon diameter
ith percentage restenotic area.
VUS predictors of restenosis. The univariate correlations
re shown in Table 3. Both immediate post-procedure
inimum ICA SA (r  0.37; p  0.01) and ICA stent
xpansion (r  0.44; p  0.001) correlated negatively
ith percentage restenotic area at 6-month follow-up.
uperficial calcium subtending two or more quadrants by
VUS was associated with higher percentage restenotic area
53.4  37.4% vs. 34.5  38.1%; p  0.05) but was no
onger significant after adjustment for either post-procedure
inimum ICA SA (p 0.87) or stent expansion (p 0.29)
y multivariate ANCOVA.
The absolute amount of ICA NIH correlated with
ercentage restenotic area at follow-up (r 0.40; p 0.01).
he correlation was strongest when the amount of ICA
IH was expressed as a percentage of the stent area (r 
.73; p 0.001). Conversely, there was no relation between
ercentage ICA late stent enlargement and percentage
estenotic area (r  0.04; p  0.78).
ISCUSSION
he present study uses serial IVUS imaging to provide a
etailed understanding of carotid artery remodeling and
estenosis after self-expanding stent deployment. The major
ndings were the following: 1) marked late enlargement of
he stent at six-month follow-up, with an average 49%
ernal carotid artery (ICA) reference vessel diameter (mm) measured byal int
months. (Right) Correlation between the immediate post-procedure ICA
e restenotic area after six months.
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June 20, 2006:2390–6 IVUS and Carotid Stent Restenosisncrease in stent area at the site of the ICA lesion; 2) 37%
verage loss of luminal area at the site of the ICA lesion
rom neointimal proliferation at six months; 3) greater late
tent enlargement correlated closely with more neointimal
ormation; as a result, the amount of NIH determined the
estenotic area and the degree of late stent enlargement did
ot; and 4) post-procedural ICA stent dimensions including
tent expansion, MLD, and minimal SA were strong
redictors of restenosis, measured by either QCA or IVUS.
elf-expanding stent enlargement, chronic injury, and
eointima proliferation. Serial IVUS studies have found
hat self-expanding stents deployed in coronary arteries
ontinue to enlarge and that the stent area increases between
5% and 33% by six months (10–12). However, when
ompared to balloon-expandable stents, they also induce up
o 30% to 40% more NIH, and the overall late lumen loss
etween the two stent designs is similar (11,12). In the
arotid territory, our findings mirror the findings of these
oronary studies; the carotid stent enlarged along its entire
ength, but it came at the expense of exaggerated neointimal
roliferation, translating into a small net lumen loss at six
onths. There are no other CAS IVUS studies, but
illfort-Ehringer et al. (14), using serial external duplex
ltrasound, reported that self-expanding carotid stents en-
arged by between 17% and 40%. However, neointimal
roliferation was such that they also found negative arterial
emodeling prevailed.
Why do self-expanding carotid stents induce such
arked neointimal proliferation? The most likely explana-
ion is that the stent (median diameter 8 mm in the present
tudy) is oversized compared with the internal carotid artery
nd that this chronic expansile force causes ongoing injury
o the deep wall, promoting greater neointima (18–20). The
trong correlation between the amount of late stent enlarge-
ent and neointima in our study supports this. von Birgelen
t al. (21) found a similar correlation in the coronary
irculation after oversized self-expanding stents were de-
loyed in coronary arteries. Other factors important in
oronary stent design, such as strut thickness or the type of
etallic alloy, may also affect the amount of carotid neoin-
able 3. Correlation Between IVUS Variables and Percentage
estenotic Area at Follow-Up
IVUS Variable r p
ost-procedure
Distal ICA reference MLD (mm) 0.03 0.82
Distal ICA reference SA (mm2) 0.04 0.81
ICA MLD stent (mm) 0.38 0.01
ICA CCA stent (mm2) 0.37 0.01
ICA stent expansion (%) 0.44 0.001
eointima and stent enlargement
ICA NIH (mm2) 0.40 0.01
ICA % NIH (%) 0.73 0.001
ICA %  stent (%) 0.04 0.78
esults refer to Pearson correlation except where indicated.
MLD  minimal luminal diameter; other abbreviations as in Tables 1 and 2.ima (22,23). However, the present study was not large dnough to assess for variable neointimal proliferation be-
ween different stent designs.
redictors of restenosis and clinical implications. The
nal post-procedural stent dimensions measured by either
CA or IVUS are strong predictors of coronary restenosis
8,9). Because the carotid artery is a much larger caliber
essel than the coronary, it has been thought that optimal
tent expansion may not be necessary. However, this study
as demonstrated that an underexpanded carotid stent with
small final lumen post-procedure has a higher risk of
estenosis. In coronary arteries, the mean size of the prox-
mal and distal reference lumen is a predictor of restenosis
8,9). However, we found the distal internal carotid refer-
nce lumen was not a determinant of restenosis.
We have previously reported the safety and feasibility of
VUS-guided CAS and found it useful to assess severe
uperficial calcification (a predictor of stroke in this study),
tent apposition, and plaque prolapse (2). However, its
outine use to assess post-procedural stent dimensions will
emain limited because of a potential small increase in
hromboembolic risk and increased procedure time. In the
bsence of IVUS, on-line QCA could be used as a surrogate
o identify those patients with small final stent dimensions
t risk of restenosis.
Should efforts be made to make the final post-procedure
arotid lumen as large as possible to reduce the risk of
estenosis? That is a double-edged sword, because high
ost-dilation pressures may increase the risk of embolization
nd perforation and induce greater neointimal formation
11,18,24,25). Progressive carotid stent enlargement is such
hat if neointima was minimized, restenosis and the need for
ggressive post-dilation would be virtually eliminated. The
ole of self-expanding carotid stents eluting agents, such as
irolimus or paclitaxel, that inhibit neointima (26,27) may
erit further investigation.
tudy limitations. This study is observational with a mod-
st sample size, although the data was collected prospec-
ively and adjudicated independently. Significant clinical
nd procedural predictors of restenosis may have been
etected with a larger number of patients. Patients were
igh risk for CEA with advanced vascular disease, and
ne-quarter were restenotic after previous surgery, so the
ndings may not be generalized to all patients with carotid
isease. The mean follow-up was only six months, and
urther longer-term vessel remodeling and stent enlarge-
ent may occur. If measurement of the EEM had been
easible, remodeling of the entire carotid wall could have
een assessed. Volumetric IVUS assessment may have better
ccuracy (28), although two-dimensional measurements
ere made at multiple sites.
onclusions. This serial IVUS study shows that although
elf-expanding carotid stents generate considerable neointi-
al hyperplasia, the process is balanced by marked late stent
nlargement. Small post-procedural internal carotid stent
imensions were associated with a higher risk of restenosis.
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